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Four types of benzisothiazole derivatives, 3-(4-alkyVaryl-2-thiazolylYl,2-benzisothiazoles Ia-f 3-(4-aryl-5-
carboxymethyl-2-thiazolyl}-I,2-benzisothiazoles 2, 3-(4-carboxymethyl-2-thiazolyl}-1,2-benzisothiazole 3 and 3-(5-
acetyl-4-methyl-2-thiazolyl}-l,2-benzisothiazole 19 have been synthesized as potential antiinflammatory agents. All the
target compounds and some selected intermediates have been assayed for their antiinflanunatory activity. some of these
compounds possess excellent level of antiinflammatory activity.
The search for more effective non-steroidal
antiinflarrunatory drugs (NSAIDs) has led medicinal
chemists to explore a wide variety of chemical
structures. A majority of these compounds,
especially those with proven clinical efficacy, are
acidic in nature such as aspirin, indomethacin,
flufenamic acid, ibuprofen, etc. Since the discovery
of aspirin, much efforts have been concentrated to
the development of acedic NSAIDs and some of
these, having an acetic acid grouping'< are found to
possess significant antiinflammatory activity.
Appreciation of these findings and as a part of our
ongoing prograrnme':" towards the development of
NSAIDs, coupled with the observation that several
1,2-benzisothiazoles and their l,l-dioxides possess
good antiinflammatory activity', our attention has
been directed on the variation of the 1,2-
benzisothiazole moiety by introducing heterocyclic
systems bearing acetic acid function with a view to
synthesize new analogues with improved
antiinflarrunatory activity". In this communication,
we report the synthesis of a few series of
compounds such as 3-(4-alkyl or arylthiazol-2-yl)-
1,2-benzisothiazoles la-f, 3-(5-acetyl-4-
methylthiazol- 2-yl)-1 ,2 -benzisothiazole 1g, 3-(4-
aryl- 5-carboxymethyl-thiazol- 2-yl)-1,2 -benzisothia-
zoles 2 and 3-(4-carboxymethylthiazol-2-yl)-1,2-
benzisothiazole 3. These compounds have been
synthesized following the reaction sequence shown
in Scheme I.
The conventional method for preparing
.~ioamides by treating the corresponding amides
with phosphorus pentasulphide failed to give the
hitherto unknown thioamide 6 from 1,2-
benzisothiazole-3-carboxamide 4. So, the required
thiocarboxamide 6 was prepared from 1,2-
benzisothiazole-3-carboxamide 4 through the 3-
cyano compound 5. The carboxamide 4 on
treatment with phosphoryl chloride afforded 1,2-
benzisothiazole-3-carbonitrile 57 which on treatment
with hydrogen sulphide and ammonia gas in ethanol
gave 1,2-benzisothiazole-3-thiocarboxamide 6 in
72% yield. The structure of 6 was established by
IR and mass spectra. The IR spectrum displayed
peaks at 3342,3273: 3184 (NH str.) and 1622 em"
(NH bend.). Moreover, the absorption peak due to
CN in the IR spectrum of carbonitrile 5 was absent
in the IR spectrum of 6. The mass spectrum of 6
showed the molecular ion [Mt at mJz 193.9977
(calcd Mol. wt 193.9978). Condensation of 6 with
chloroacetone, phenacyl bromides and 1-acetyl-l-
bromoacetone according to the well known
Hantzsch thiazole synthesis gave 1 in 66-81 % yields
(Table I).
Compound 6 on condensation with various ethyl
p-aroyl-p-bromopropionates gave 3-(4-aryl-5-
carbethoxymethylthiazol- 2-yl)-:1,2-benzisothiazoles
7 in good yields (65-68%, cf. Table I) which on
alkaline hydrolysis in methanol followed by
acidification 'afforded the corresponding acids 2 in
91-97% yields (Table I). The IR spectra of all the
esters 7 showed an intense peak at 1730 em"
(C=O). The hydrolysed acids 2 exhibited apart
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from a band at 1695 cm' (C=O), a broad band in
the region 2800-2600 cm' due to hydrogen bonded
OH stretching. The characteristic triplet-quartet
pattern present in the lH NMR spectra of 7 was
absent in the lH NMR spectra of 2. The signal for
CH2 protons of CH2COOH group in 2 and 7
appeared as a singlet at 03.9.
1,2-Benzisothiazole-3-thiocarboxamide 6 also
underwent condensation with ethyl y-
bromoacetoacetate smoothly in ethanolic solution
giving the required 3-(4-carbethoxymethylthiazol-2-
yl)-1,2-benzisothiazole 8 in 64% yield which on
basic hydrolysis with 5% sodium hydroxide in
methanol afforded the corresponding acetic acid 3.
The IR spectrum of the ester 8 showed a band at
1725 em'! (C=O), whereas the acid showed peaks at
1695 (C=O) and a broad peak in the region 2800-
2600 ern" (hydrogen bonded OH of acid). The
b) BrC~COCH2COOC2Hs, EtOH, ~ ;
d) 7% KOH, MaOH, ~ ;
Scheme I
signal due to CH2 protons of CH2COOH group
appeared as singlet at 03.8 in the !H NMR spectra
of3 and 8.
Antiinflammatory activity. Compounds 1-3,6 and
7 were tested for their antiinflammatory activity by
acute carrageenin-induced rat paw edema tests. The
compounds were administered as suspension in gum
acacia (1% w/v) in normal saline. Male albino
Charles Foster rats weighing between 110 and 140
g were divided into groups of four each. Edema was
induced by injecting 0.1 mL of carrageenin solution
into the left hind paw. The compounds were
administered at a dose of 100 mg/kg orally one hour
before or intraperitoneally half an hour before
carrageenin injection. The paw volume of the limbs
was measured with a volume differential meter
immediately before and 2 hr and 3.5 hr after
carrageenin injection. In every set of experiments,
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Compd" R
Table I- Characterization data of new compounds prepared
RI m.p. Yield Mol.formula Calcd (%) (Found)
°c (%) (M'")b C H N
H 112 63 CllHaN2S2 (56.9 3.4 12.1)
(232.0152) 56.6 3.3 12.2
H 128 75 CuJlloN2S2 (65.3 3.4 9.5)
65.2 3.3 9.4
H 136 66 C17H12N2S2 (66.2 3.9 9.1)
(308.0294) 66.0 3.6 9.0
H 120 69 CI7HI2N,oS2 (63.0 3.7 8.6)
62.7 3.5 8.6
H 153 81 CIJI~IN2S2 (58.4 2.7 8.5)
(327.9823/ 58.4 2.5 8.3
329.9795)
H 260 71 CISH~J82 (61.0 3.1 14.2)
61.1 3.3 14.3
COCH3 176 75 CJ3HloN20S2 (56.9 3.6 10.2)
(274.0176) 57.0 3.7 10.0
235 94 ClsH12N2o,S2 (61.4 3.4 8.0)
(352.0207) 61.7 3.6 8.1
207 91 CI~I~20J82 (59.7 3.7 7.3)
(382.0379) 59.6 3.5 7.0
245 97 CisHIICIN2o,S2 (55.9 2.8 7.2)
55.6 2.6 7.5
185 88 C12HaN2o,S2 (52.2 2.9 10.1)
(276.0033) 52.3 3.1 10.0
128 68 C2oHl~2o,S2 (63.2 4.2 7.4)
(380.0654) 63.0 4.2 7.3
119 65 C21HIsN203S2 (61.5 4.4 6.8)
(410) 61.4 4.1 6.7
134 68 C2oHuCIN2O,S2 (57.9 3.6 6.8)
57.6 3.5 6.5

















aAll the compounds were crystallized from ethanol.
bCorrect masses were found by HRMS
one group of fats was kept as control and
administered only the vehicle I% gum acacia,
whereas another group received a standard drug
(ibuprofen) for comparison. The results were
evaluated as percent inhibition as compared with the
control group. Local irritant action was tested by
applying different concentrations of test compounds
on the rabit cornea". The results are given in Table
II.
Although the compounds tested do not follow any
general pattern in exhibiting AI activity, certain
observations are worthmentioning. Most of the
compounds show higher inhibition when
administered intraperitoneally as compared to the
oral route. The activity decreases rapidly with the
passage pf time as inhibition measured after 2 hr
period is generally more than that observed after 3.5
hr indicating thereby that these compounds are
rapidly metabolised in the system. Amongst the
target compounds the highest activity was exhibited
by compound 2c (inhibition 75% p.o.) followed by
3 with inhibition of 64% (p.o.). Moreover, the
compound 2c had quite high activity (69%
inhibition) even at dose level of 50 mg/kg. This is
somewhat expected because these compounds (2c
and 3) belong to the family of heterocyclyalkanoic
acids. The high activity puts these compounds in a
class of potential NSAIDS and therefore they have
been marked for detailed phannacologica1
screening. The order of activity shown by the
compounds within the series 2 i.e. 2c>2b>2a is in
confinnatioo of our earlier observation that
compounds with chloro or methoxy substituents
show higher activity'". Another compound 6 has
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for 1 hr, cooled and poured into cold water. The
resulting solid was filtered, dried under vacuum,
and crystallized from ethanol, mp 91°C (Lie, mp
83-85°C), yield 1.3 g (81%); IR : 2234 (C-N str.).
1,2-Benzisothiazole-3-thioearboxamide 6. 1,2-
Benzisothiazole-3-carbonitrile 5 (1.6 g, 0.0 I mole)
was dissolved in ethanol (20 mL). Ammonia gas
was passed through the solution till saturated,
followed by passing of the dry hydrogen sulphide
gas. The product 1,2-Benzisothiazole-3-
thiocarboxamide 6 crystallized out rapidly on
standing of the reaction mixture for sometime at
room temperature, filtered, washed with cold
ethanol, dried and crystallized from ethanol mp
98°C, yield 1.4 g (72%); IR: 3342, 3273, 3184 (NH
str.), 1622 (NH bend.); IH NMR (CDCh): 7.2-7.6
(m, 2H, Ar-H), 7.6-7.9 (m, IH, Ar-H), 8.3-8.8 (bs,
NH), 9.1-9.4 (m, IH, Ar-H); MS: ~ at m/z
193.9977; Calcd Mol. wt. 193.9978. Anal. Calcd
Each value is the mean of four animals. for C8~2S2: C,49.5; H, 3.1; N, 14.4. Found: C,
N:S;IOO/O inhibition 49.0; H, 3.3; N, 14.0%.
ND denotes not done. 3-[ 4-(p- Toluyl)thiazol--2-yl ]-1,2-benzisothiazole
·Value is the mean of eight animals. Ic, A mixture of 1,2-Benzisothiazole-3-thiocar-
"Percent inhibition at 50 mg/kg._.!..!:!.::::!!:~~~'="'::==El.:.- boxamide 6 (1.94 g, 0.0 I mole) and p-
shown activity comparable with that of ibuprofen methylphenacyl bromide (2,13 g, 0.01 mole) in
and has also been chosen for detailed ethanol (50 mL) was refluxed for 6 he. The volume
pharmacological study. was reduced to half and the solid which separated
out was filtered and treated with aqueous ammonia.
The product was collected by filteration, washed
with water, dried and crystallized from ethanol, mp
136°C, yield 2.0 g (66%); IR: No absorption in the
region 3400-3100 and 1800-1650 (NH and C=O
absent); IH NMR (CDCh) : 2.4 (s, 3H, CH3), 7.1-
8.1 (m, 8H, Ar-H and thiazole 5-H), 9.1-9.4 (m,
IH, Ar-H); MS : ~ at m/z 308.0294; Calcd Mol.
wt. 308.0447.
Other compounds in the series were prepared
similarly and are listed in Table I.
3-[ 4-(p-Anisyl)-5-carbethoxymethylthiazol-2-yl l-
1,2-benzisothiazole 7b. To a solution of 1,2-
benzisothiazole-3-thiocarboxamide 6 (1.94 g, 0.01
mole) in ethanol (25 mL) was added a solution of
ethyl p-(P-anisoyl)-p-bromopropionate (2.85 g,
0.01 mole) in ethanol (25 mL). The reaction
mixture was refluxed for 4 hr, cooled and kept
overnight. The crystalline solid which separated out
was filtered, washed with sodium bicarbonate
solution (2%) and then with water, dried and
crystallized from ethanol, mp 119°C, yield 2.7 g
Table n- Antiinflammatory activity of compounds 1-3,6,7
on oral (p.o.) and intraperitoneal (i.p.) administration
Compd % inhibition
Experimental Section
General. Melting points were determined in open
capillaries in a sulphuric acid-bath and are
uncorrected. IR spectra were scanned as nujol
mulls on a Perkin-Elmer 842 infrared
spectrophotometer (vrnax in em"). IH NMR spectra
were recorded on a Perkin-Elmer R-32 (90 MHz)
instrument (chemical shifts in 0, ppm) using TMS
as internal standard, and mass spectra at 70 eV on
MS-12, DS-55 and MS 30IDS 50S mass
spectrometers.
1,2-Benzisothiazole-3-carboxamide 411, ethyl p-
aroyl-Bcbromopropionates 12, ethyl y-bromoaceto-
acetate 13 and l-acetyl-I-bromoacetonc'" were
prepared according to the literature methods.
t,2-Benzisothiazole-3-carbonitrile 5. 1,2-
Benzisothiazole-3-carboxamide 4 (1.78 g, 0.01
mole) was placed in a round bottomed flask and
phosphoryl chloride (5 mL) added to it. The
reaction mixture turned hot with the dissolution of
the carboxamide. The solution was then refluxed
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(65%); IR : 1730 (C=O str. of COOC2Hs); IH
NMR (CDCh) : l.25 (t, 3H, COOCH2CH3), 3.8 (s,
3H, OCH3), 3.9 (s, 2H, CH2COOC2Hs), 4.2 (q, 2H,
COOCH2CH3), 6.8-8.0 (m, 7H, Ar-H); MS : M+ at
m/z 410; Calcd mol. wt. 410.
Other compounds in the series were prepared
similarly and are listed in Table I.
3-[ 4-(p-Anisyl)-5-carboxymethylthiazol-2-yl ]-
1,2-benzisothiazole 2b. To a solution of 3-[ 4-(p-
anisyl)-5-carbethoxymethylthiazol-2-yl ]-1,2-benzi-
sothiazole 7b (4.10 g, 0.01 mole) in methanol (20
mL) was added potassium hydroxide solution (7%,
20 mL) and the mixture heated under reflux for 1
hr. After cooling, the solution was filtered from any
undissolved matter and the filtrate acidified with
glacial acetic acid. The product so obtained was
filtered, washed with water, dried and crystallized
from ethanol, mp 207°C, yield 3.48 g (91 %); IR :
2800-2600 (hydrogen bonded OH of COOH), 1694
(C=O str.); IH NMR (DMSO-d6 CDCI3) : 3.8 (s,
3H, OCH3), 3.9 (s, 2H, CH2COOH), 6.7-8.1 (m,
7H, Ar-H), 8.9-9.2 (m, IH, Ar-H),; MS: ~ at m/z
382.0379; Caled Mol. wt. 382.0451.
Other compounds in the series were prepared
similarly and are listed in Table I.
3-( 4-carbethoxymethylthiazol- 2-yl)-1 ,2-benziso-
thiazole 8. To an ice cold solution of ethyl y-
bromoactoacetate (2.09 g, 0.0 1 mole) in ethanol (15
mL) was added a solution of 1,2-benzisothiazole-3-
thiocarboxamide 6 (1.94 g, 0.01 mole) in ethanol
(20 mL) and the mixture stirred for 15 hr. The
unreacted ester was removed on shaking with ether.
The aqeous layer was neutralized with aqeous
sodium bicarbonate. The solid which separated out
was filtered, washed with sodium bicarbonate References
solution (2% and then with water, dried and I Walsh D A, Moran H W, Shamblee D A, Welstead W J,
crystallized from ethanol, mp 96°C, yield l.95 g Nolan J C, Sancilio L F & Graff G, J Med Chem, 33,
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H, 3.9; N, 9.2. Found: C, 55.0; H, 4.3; N, 9.2%. (b) Sawimey S N & Sharma P K, Gupta A, Singh G 13&
3-( 4-carboxymethylthiazol-2-yl)-1 ,2-benziso- Bani S, Indian JChem, 318, 1992, 421.
thiazole 3. . A suspension of 3-(4- (c) Sawhney S N, Sharma P K, Gupta A, Singh G 8 &
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solution (5%, 25 mL) was refluxed for 2 hr, cooled (b) Sawimey S N, Vir D & Gupta A, Indian J Chem, 298,
and diluted with water. It was filtered to remove 1990, 1107.
any undissolved impurity and the filtrate rendered
acidic with acetic acid. The solid product, thus
obtained, was filtered, washed with water, dried and
crystallized from ethanol, mp 185°C, yield 1.2 g
(88%); IR : 2800-2600 (hydrogen bonded O-H of
COOH), 1695 (C=O str.); IH NMR (DMSO-
dJCDCb) : 3.8 (s, 2H, CH2COOH), 6.9-8.1 (m,
4H, Ar-H and thiazole 5-H), 8.8-9.2 (m, IH, Ar-H);
MS : ~ at m/z 276.0033; Caled. Mol. wt.
275.9758. Anal. Calcd for C12HgN202S2:C, 52.2;
H, 2.9; N, 10.1. Found: C, 52.3; H, 3.1; N, 10.0%.
3-(5- Acetyl-4-methylthiazol- 2-yl)-l ,2-benziso-
thiazole 19. To a solution of l-acetyl-l-
bromoacetone in ethanol (30 mL) was added a
solution of 1,2-benzisothiazole-3-thiocarboxamide 6
(1.94 g, 0.01 mole) in ethanol (15 mL) and the
mixture refluxed for 3 hr. The crystalline solid
which separated out on cooling was filtered and
treated with aqeous anunonia. The solid product
was collected by filtration, washed with water,
dried and crystallized from ethanol, mp 176°C,
yield 2.05 g (75%); IR : 1667 (C=O str.); IH NMR
(CDCb): 2.6 (s, 3H, CH3), 2.85 (s, 3H, COCH3),
7.1-8.1 (m, 3H, Ar-H), 9.0-9.3 (m, IH, Ar-H); MS
: ~ at m/z 274.0176; Caled. Mol. wt. 274.0240.
Anal. Calcd for C13HlON20S2: C, 56.9; H, 3.6; N,
10.2. Found: C, 57.0; H, 3.7; N, 10.0%.
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